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CASE PRESENTATION
A 57-year-old woman was referred for evaluation of
new-onset hypertension and proteinuria. The patient had
developed lower extremity edema 3 months prior and had
been treated with diuretics. Past medical history was
significant for microscopic hematuria of many years’
duration thought secondary to nephrolithiasis,
longstanding arthritis of the hands and hips, depression,
and deep venous thrombosis that occurred following
arthroscopic surgery. There was no history of fever, skin
rash, oral ulcers, alopecia, or photosensitivity.
On physical examination, the patient was found to
have a blood pressure of 150/94 mmHg. She was obese
(height 5 ft and 6 inch, weight 262 lb). Cardiovascular and
pulmonary examinations were unremarkable. There was
no evidence of edema or hepatosplenomegaly. Her hands
showed Heberden’s and Bouchard’s nodes bilaterally.
The patient’s medications included valsartan 320 mg daily,
amlodipine 10 mg daily, raloxifene 60 mg daily,
amitriptyline 25 mg daily, and potassium citrate 10 mEq
twice per day for nephrolithiasis.
Laboratory evaluation showed a total leukocyte count
of 5600/mm3 (normal range 4300–10 800/mm3) with
normal differential, hemoglobin 13.4 g/dl (134 g/l) (normal
range, 13–18 g/dl (130–180 g/l)), platelet count 238 000/
mm3 (normal range, 150 000–500 000 mm3), serum sodium
141 mmol/l (normal range, 135–145 mmol/l), serum
potassium 4.6 mmol/l (normal range, 3.5–5.5 mmol/l),
serum bicarbonate 28 mmol/l (normal range, 22–26 mmol/
l), blood urea nitrogen 26 mg/dl (9.3 mmol/l) (normal
range, 10–30 mg/dl (3.6–10.7 mmol/l)), serum creatinine
0.6 mg/dl (53 lmol/l), estimated glomerular filtration rate
162 ml/min, albumin 2.5 g/dl (25 g/l) (normal range,
3.5–4.9 g/dl (35–49 g/l)), 24 h urine protein 1200 mg/day
(normal range 0–150 mg/day), and cholesterol 170 mg/dl
(4.4 mmol/l) (normal range, 130–200 mg/dl
(3.36–5.17 mmol/l)). Serologic evaluation revealed an
anti-nuclear antibody (ANA) titer of 1:640 with speckled
pattern and normal serum complement levels. The
following serologies were negative: anti-double-stranded
DNA antibody, rheumatoid factor, serum cryoglobulins,
hepatitis B surface antigen, and hepatitis C antibody.
Urinalysis showed 2þ protein and 1þ blood. Microscopic
evaluation revealed 5–10 red blood cells per high-power
field, without red blood cell casts. Computerized
tomography scan showed symmetric, normal-sized
kidneys with multiple bilateral small non-obstructing
calculi. Over the course of 3 months, the 24 h urine protein
increased to 8 g/day while the creatinine remained
unchanged. The referring nephrologists suspected lupus
nephritis based on the positive ANA and history of
arthritis. A renal biopsy was performed.
KIDNEY BIOPSY FINDINGS
The kidney biopsy contained 16 glomeruli for light micro-
scopy, four of which were globally sclerotic. The remaining
glomeruli appeared enlarged with variable membranoproli-
ferative features in the form of mild mesangial hypercellu-
larity and segmental to global duplication of glomerular
basement membranes (Figure 1a). There were abundant large
intraluminal deposits forming glassy ‘protein thrombi’ that
stained strongly eosinophilic with the hematoxylin and eosin
stain, weakly periodic acid–Schiff positive, trichrome-red,
non-argyrophilic, and Congo red-negative (Figure 1b). Some
of these deposits extended into the subendothelial region and
were associated with infiltrating macrophages containing
prominent trichrome-red phagolysosomes. No neutrophil
infiltration, necrotizing lesions, or crescents were identified.
There was mild focal tubular atrophy and interstitial fibrosis
involving approximately 10% of the cortex, accompanied
by a sparse interstitial infiltrate of mononuclear cells. There
was mild arterio- and arteriolosclerosis. No arteritis or
intravascular deposits were seen.
Twelve glomeruli were studied by immunofluorescence
(IF) and showed 2þ granular global mesangial and
segmental glomerular capillary wall and luminal staining
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for IgG and kappa, with only trace IgM and lambda, negative
IgA, 1þ C3, and 1þ C1q. There was also positive tubular
epithelial cell nuclear staining (speckled pattern) for IgG,
consistent with ‘tissue ANA’. IF staining for IgG1–4 subclasses
showed 3þ staining of the deposits for IgG3, with trace to
negative IgG1, negative IgG2, and negative IgG4 (Figure 1c).
By electron microscopy, the glomerular capillary lumina
were segmentally occluded by large highly electron-dense
subendothelial and intracapillary deposits, forming ‘protein
thrombi’. Deposits were associated with numerous infiltrating
macrophages containing large phagolysosomes (Figure 1d).
Many of the macrophages appeared to be phagocytosing
the adjacent subendothelial and intraluminal deposits. On
high-power examination, the deposits had a glassy homo-
genous texture without evidence of substructure. A few
small mesangial electron-dense deposits were also present.
Foot-process effacement involved approximately 90% of
the glomerular capillary surface area. No tubuloreticular
inclusions or tubulointerstitial electron-dense deposits were
identified.
Differential diagnosis
Differential diagnosis of this proliferative glomerulonephritis
with membranoproliferative features and prominent intra-
capillary deposits includes cryoglobulinemic glomerulone-
phritis and lupus nephritis. The abundant glassy
intracapillary deposits with numerous infiltrating macro-
phages containing large phagolysosomes are most typical of
cryoglobulinemic glomerulonephritis, although cryoglobulin
titers were reportedly negative and there was no hypocom-
plementemia or deposit substructure. In addition, the
hypereosinophilia of the deposits was more characteristic of
the ‘protein thrombi’ of cryoglobulinemia than the ‘hyaline
thrombi’ of lupus nephritis. Because of the dominant
staining for IgG, kappa, and IgG3 subclass, a type I
cryoglobulin (containing monoclonal IgG3k) was suspected.
Figure 1 | (a) Segmental duplication of glomerular basement membrane (arrows) is delineated with the Jones methenamine silver
stain (original magnification  600). (b) A glomerulus with abundant non-argyrophilic intracapillary deposits forming ‘protein thrombi’
(Jones methenamine silver stain, original magnification  400). (c) A glomerulus stained by IF for IgG3 is strongly positive. There was trace
to negative staining for IgG1, negative IgG2, and negative IgG4 (not shown), indicating restriction to a single gamma subclass (original
magnification  400). (d) Electron microscopy shows a large highly electron-dense subendothelial deposit adjacent to an infiltrating
macrophage. The macrophage contains numerous phagolysosomes with the same electron density as the subendothelial deposit, suggesting
phagocytosed immune material (original magnification  4000).
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Although the positive serum ANA and the presence of ‘tissue
ANA’ raised the possibility of lupus nephritis, the absence of
‘full-house’ IF staining, the absence of endothelial tubulo-
reticular inclusions, and the absence of extraglomerular
deposits made this diagnosis unlikely.
CLINICAL FOLLOW-UP
Following the results of renal biopsy, serum protein
electrophoresis was performed and showed a faint abnormal
protein band in the gamma region. Serum immunofixation
and urine immunofixation revealed an IgGk monoclonal
protein in both the serum and urine. The patient underwent
a bone marrow biopsy, which showed mild hypercellularity
with 5% scattered atypical plasma cells consistent with early
multiple myeloma. Treatment was initiated with low-dose
dexamethasone and thalidomide. Two months following
biopsy, repeat serum cryoglobulin test was positive and
immunofixation performed on the cryoprecipitate revealed a
type 1 cryoglobulin composed of monoclonal IgGk (repre-
senting 75% of the total IgG in the cryoprecipitate), admixed
with albumin and traces of other plasma proteins. Additional
laboratory results obtained 2 months post biopsy included
urine protein (random) 1560 mg/l, serum albumin 2.9 g/dl
(29 g/l), serum creatinine 0.6 mg/dl (53 mmol/l), normal
serum complement, normal C reactive protein, negative
rheumatoid factor, positive ANA titer at 1:640 with speckled
pattern, and negative anti-double-stranded DNA antibody.
FINAL DIAGNOSIS
Type I cryoglobulinemic glomerulonephritis.
DISCUSSION
Cryoglobulins are immunoglobulins that precipitate when
serum is cooled to below 371C and dissolve with rewarming.
Brouet et al.1 classified cryoglobulins into three types. Type I
cryoglobulins consist of a single monoclonal immuno-
globulin (usually of IgG or IgM class) and are associated
with plasma cell dyscrasias or other lymphoproliferative
disorders. Type II cryoglobulins are mixed cryoglobulins
containing monoclonal immunoglobulin (usually IgM
kappa) with rheumatoid factor activity for polyclonal
immunoglobulin (usually IgG). This type is seen most
commonly in association with hepatitis C virus infection,
and is most frequently implicated in glomerulonephritis.
Other causes of type II cryoglobulinemia include dyspro-
teinemia, other chronic infections, and autoimmune disease.
Type III cryoglobulins are mixed cryoglobulins composed of
polyclonal immunoglobulins (often IgG and IgM, and less
commonly IgA). This form is often seen in association with
infections and autoimmune disease.
Glomerulonephritis secondary to type I cryoglobulinemia
is rare. Although clinical evidence of renal involvement was
present in 25 and 40% of cases of type I cryoglobulinemia
described by Brouet et al.1 and Trejo et al.,2 respectively, no
descriptions of the renal histologic findings were provided.
Only 21 biopsy-proven cases of glomerulonephritis associated
with type I cryoglobulins have been reported in the English
literature.3–17 Sixteen of these 21 cases (76%) had a
monoclonal IgG cryoglobulin detectable in the serum (of
kappa isotype in 12 of the 13 cases studied); four (19%)
resulted from a monoclonal IgM (of kappa isotype in two of
the four cases); and one (4%) was associated with a double
monoclonal protein composed of IgAl–IgGl. In eight patients
(38%), type I cryoglobulins were associated with hematologic
malignancies (four chronic lymphocytic leukemias, one
multiple myeloma, and three lymphomas, including one
angioimmunoblastic lymphoma, one mantle cell lymphoma
and one non-classified lymphoma). All 21 patients presented
with proteinuria, and full nephrotic syndrome was present in
eight cases (38%). Renal insufficiency was present in 16
patients (76%) and mean serum creatinine was 2.97 mg/dl
(263mmol/l) (range 0.96–9.40 mg/dl (85–831mmol/l)). Fifteen
patients (71%) had microscopic hematuria. Skin manifesta-
tions, including Raynaud’s phenomenon and purpura, were
present in 11 patients (52%). Serum complement was low in
58% of patients (11 of 19), and rheumatoid factor activity was
present in 45% (nine of 20).
On renal biopsy, membranoproliferative glomerulone-
phritis was the predominant histologic pattern. Seven cases
(29%) showed intracapillary protein thrombi. Cellular
crescents and renal small vessel vasculitis each were seen in
three cases (14%). The glomerular deposits in seven of the 12
cases (58%) studied ultrastructurally displayed an organized
substructure (fibrillar in four, microtubular in two, and
‘fingerprint’ in one). IF was performed in 18 cases. The
glomerular deposits were composed of a single immuno-
globulin and complement in 10 (55%), a single immuno-
globulin without complement in four (22%), two
immunoglobulins (IgG and IgM) with complement in three
(16%), and C3 only in one (5%). Characterization of
immunoglobulin heavy-chain isotype in the glomerular
deposits was performed in only three patients.8,16 In the
two cases described by Karras et al.,16 the circulating
cryoglobulin and glomerular deposits consisted of IgG3k,
whereas IgG1l was found in the serum and the kidney in the
case reported by Touchard et al.8 Most of the patients were
treated with steroids and one or more immunosuppressive
agents (including cyclophosphamide, azathioprine, or chlor-
ambucil). Improvement in renal function (decreased protein-
uria and serum creatinine) was achieved in 11 patients
(52%), although data on long-term prognosis are lacking.
We describe an additional case of type I cryoglobulinemic
glomerulonephritis. Clinically, the patient complained of a
history of several years of joint pain before she developed
nephrotic range proteinuria and microscopic hematuria. At
the time of biopsy, she had normal serum complement and
no serum cryoglobulin was detectable. Renal biopsy showed a
membranoproliferative pattern with prominent intracapillary
‘protein thrombi’, some of which were being phagocytosed
by infiltrating macrophages. The glomerular deposits
were composed of monoclonal IgG3k and complement. A
monoclonal serum protein and a type I serum cryoglobulin
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were detected 2 months later, each of which exhibited the same
heavy- and light-chain isotypes as the glomerular deposits.
Our case and review of the previously reported literature
highlight several important distinctions between type I and
type II cryoglobulinemic glomerulonephritis. First, glomerulo-
nephritis due to type I cryoglobulinemia is relatively rare.
Whereas hypocomplementemia is found in the majority of
cases of type II cryoglobulinemic glomerulonephritis, it
occurs in only half of the patients with type I cryoglobuli-
nemic glomerulonephritis. Type 1 cryoglobulins are notor-
iously difficult to identify and may elude detection by
standard methods, requiring multiple screenings over time.
Accordingly, initial cryoglobulin screens were negative but a
repeat study was positive 2 months following biopsy in our
case and as long as 9 years following presentation in the
report by Ishimura et al.12 Finally, in type 1 cryoglobuline-
mia, the use of immunostaining for IgG subclasses (1–4) is an
extremely helpful ancillary test to support monoclonality of
the glomerular IgG deposits in cases where routine IF reveals
light-chain restriction. This is particularly important in
patients without a detectable monoclonal serum protein
owing to its presence at very low titers, below the level of
detection by standard immunoelectrophoresis.
The identification of IgG3 in the glomerular deposits of
our case and the two cases described by Karras et al.16
supports a pathogenetic role for this particular subclass,
which comprises only 8% of the total serum IgG. IgG3
predominates in murine cryoglobulins and is also enriched in
human type II cryoglobulins associated with hepatitis C
infection and autoimmune disorders.18–20 The cryogenic
properties of IgG3 have been attributed in part to the strong
tendency of this isotype to self-aggregate via non-immuno-
logic Fc–Fc interactions.21,22 However, not all monoclonal
IgG3 molecules are necessarily cryogenic, suggesting the
contribution of other factors. The cryogenic activity of IgG3
is enhanced by the presence of more positively charged
amino-acid residues at positions 6 and 23 of the heavy-chain
variable domain.23 Reduction in the relative galactose content
of the CH2 oligosaccharide side chains favors conformational
changes that promote precipitation of the IgG3 molecule.24,25
In addition, reduction in the number of sialic acid residues of
the CH2 oligosaccharide side chains produces a less
negatively charged, more cryogenic IgG3 molecule.26 The
glomerular deposition of type I cryoglobulins may be favored
by sieving effects, which concentrate the monoclonal protein
at the level of the glomerular capillary lumen, as well as the
interaction of the relatively positively charged IgG3 molecule
with negatively charged glomerular basement membrane
constituents.
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